Assignee
DELUCA HECTOR F
US·41 granted patents·18 pending applications·187 citations·filing 1988–2014
Top patents by PatentIndex Score
59 records- 0196US8759328B2Once-a-week administration of 25-hydroxy vitamin D3 to sustain elevated steady-state pharmacokinetic blood concentrationDELUCA HECTOR F·Filed 2009·Granted Jun 24, 2014·29 cites·41 claims
- 0286US7053075B2Methods for reducing body fat using vitamin D compoundsDELUCA HECTOR F·Filed 2004·Granted May 30, 2006·31 cites·31 claims
- 0385US4973584ANovel 1α-hydroxyvitamin D2 epimer and derivativesDELUCA HECTOR F·Filed 1989·Granted Nov 27, 1990·35 cites·7 claims
- 0483US8093232B22α-methyl-19-nor-(20S)-1α-hydroxy-bishomopregnacalciferol and its usesDELUCA HECTOR F·Filed 2007·Granted Jan 10, 2012·4 cites·57 claims
- 0582US8664206B2Diastereomers of 2-methylene-19-nor-22-methyl-1α,25-dihydroxyvitamin D3DELUCA HECTOR F·Filed 2012·Granted Mar 4, 2014·6 cites·22 claims
- 0681US8519169B2Crystallization a 1alpha-hydroxy-20-methyl-2-methylene-19,24,25,26,27-pentanorvitamin D3DELUCA HECTOR F·Filed 2012·Granted Aug 27, 2013·2 cites·16 claims
- 0781US8404874B2(20R,25S)-2-Methylene-19,26-Dinor-1α,25-Dihydroxyvitamin D3 in crystalline formDELUCA HECTOR F·Filed 2011·Granted Mar 26, 2013·2 cites·16 claims
- 0881US8114859B22-methylene-(20S,25S)-19,27-dinor-(22E)-vitamin D analogsDELUCA HECTOR F·Filed 2007·Granted Feb 14, 2012·4 cites·79 claims
- 0980US8143238B2Methods of increasing epidermal skin thickness by topical administration of a 19-nor containing vitamin D compoundDELUCA HECTOR F·Filed 2009·Granted Mar 27, 2012·2 cites·29 claims
- 1077US8193169B2(20R)-2α-methyl-19,26,2-trinor-vitamin D analogsDELUCA HECTOR F·Filed 2008·Granted Jun 5, 2012·2 cites·79 claims
- 1176US8404666B22-substituted-1α,25-dihydroxy-19,26,27-trinor vitamin D analogs and uses thereofDELUCA HECTOR F·Filed 2007·Granted Mar 26, 2013·2 cites·26 claims
- 1276US8399439B22-methylene-19,26-dinor-(20S,22E,25R)-vitamin D analogsDELUCA HECTOR F·Filed 2008·Granted Mar 19, 2013·2 cites·79 claims
- 1376US8193170B22-methylene-19,26-dinor-(20R,22E,25R)-vitamin D analogsDELUCA HECTOR F·Filed 2008·Granted Jun 5, 2012·2 cites·67 claims
- 1475US8193171B213,13-dimethyl-des-C,D analogs of 1α,25-dihydroxy-19-nor-vitamin D3 compounds and topical composition dosage forms and methods of treating skin conditions thereofDELUCA HECTOR F·Filed 2009·Granted Jun 5, 2012·2 cites·37 claims
- 1574US8604009B2(20S)-2-methylene-19-nor-22-dimethyl-1α,25-dihydroxyvitamin D3 and (20R)-2-methylene-19-nor-22-dimethyl-1α,25-hydroxyvitamin D3DELUCA HECTOR F·Filed 2011·Granted Dec 10, 2013·2 cites·20 claims
- 1673US8114393B2Methods and compositions for phosphate bindingDELUCA HECTOR F·Filed 2007·Granted Feb 14, 2012·2 cites·8 claims
- 1773US5036061AProcess for the preparation of 1 alpha,25-dihydroxylated vitamin D2 and related compoundsDELUCA HECTOR F·Filed 1989·Granted Jul 30, 1991·10 cites·16 claims
- 1871US8058265B21a-hydroxy-2-(3'-hydroxypropylidene)-19-nor-vitamin D compounds and methods of making and treatment thereofDELUCA HECTOR F·Filed 2007·Granted Nov 15, 2011·1 cites·28 claims
- 1970US8445468B2(20S,22E)-2-methylene-19-nor-22-ene-1α,25-dihydroxyvitamin D3DELUCA HECTOR F·Filed 2010·Granted May 21, 2013·1 cites·20 claims
- 2067US2014155360A1Calcium Formate for Use as a Dietary SupplementDELUCA HECTOR F·Filed 2014·Application pending·0 cites
- 2164US8232263B217,20(Z)-dehydro vitamin D analogs and their usesDELUCA HECTOR F·Filed 2007·Granted Jul 31, 2012·0 cites·16 claims
- 2263US8440647B22α-methyl and 2β-methyl analogs of 19,26,27-trinor-(20S)-1α-hydroxyvitamin D3 and their usesDELUCA HECTOR F·Filed 2007·Granted May 14, 2013·0 cites·104 claims
- 2362US2006148769A1(20S)-1alpha-hydroxy-2alpha-methyl and 2beta-methyl-19-nor-vitamin D3 and their usesDELUCA HECTOR F·Filed 2006·Application pending·0 cites
- 2462US2012046252A1Calcium Formate for Use as a Dietary SupplementDELUCA HECTOR F·Filed 2011·Application pending·0 cites
- 2560US8609643B22-methylene-(20S,25R)-19,26-dinor-vitamin D analogsDELUCA HECTOR F·Filed 2008·Granted Dec 17, 2013·0 cites·90 claims
- 2660US4970203AMethod for improving reproductive functions in mammalsDELUCA HECTOR F·Filed 1988·Granted Nov 13, 1990·29 cites·16 claims
- 2759US8222236B22-methylene-(20E)-20(22)-dehydro-19-nor-vitamin D analogsDELUCA HECTOR F·Filed 2008·Granted Jul 17, 2012·0 cites·79 claims
- 2857US8987235B2N-cyclopropyl-(20R)-2-methylene-19,26,27-trinor-25-aza-vitamin D analogs and their usesDELUCA HECTOR F·Filed 2012·Granted Mar 24, 2015·0 cites·28 claims
- 2957US2006003973A1Use of 2alpha-methyl-19-nor-20(S)-1alpha,25-dihydroxyvitamin D3 to increase bone strengthDELUCA HECTOR F·Filed 2005·Application pending·0 cites
- 3056US8575136B22-methylene-1α-hydroxy-18,19,21-trinorvitamin D3 analogs and uses thereofDELUCA HECTOR F·Filed 2007·Granted Nov 5, 2013·0 cites·27 claims
- 3155US5030772AProcess for preparing vitamin D2 compounds and the corresponding 1 α-hydroxylated derivativesDELUCA HECTOR F·Filed 1990·Granted Jul 9, 1991·13 cites·13 claims
- 3253US9452177B2Vitamin D compounds and methods for reducing ocular hypertension (OHT)DELUCA HECTOR F·Filed 2009·Granted Sep 27, 2016·0 cites·9 claims
- 3353US8604008B22-methylene-19,21-dinor-1α-hydroxy-bishomopregnacalciferolDELUCA HECTOR F·Filed 2005·Granted Dec 10, 2013·0 cites·19 claims
- 3453US8399438B22α-methyl-19-nor-1α-hydroxy-homopregnacalciferol and its usesDELUCA HECTOR F·Filed 2005·Granted Mar 19, 2013·0 cites·67 claims
- 3553US8222235B22-methylene-19-nor-(20R)-1α-hydroxy-bishomopregnacalciferolDELUCA HECTOR F·Filed 2005·Granted Jul 17, 2012·0 cites·19 claims
- 3653US2008021002A1Vitamin d compounds used to stabilize kidney transplantsDELUCA HECTOR F·Filed 2007·Application pending·0 cites
- 3753US2012071562A12alpha-Methyl-19-Nor-(20S)-1alpha-Hydroxy-Bishomopregnacalciferol and Its UsesDELUCA HECTOR F·Filed 2011·Application pending·0 cites
- 3852US5061699ACompounds effective in inducing cell differentiation and process for preparing sameDELUCA HECTOR F·Filed 1989·Granted Oct 29, 1991·4 cites·31 claims
- 3950US10479764B22-methylene-(22E)-25-hexanoyl-24-oxo-26,27-cyclo-22-dehydro-19-nor-vitamin D analogsDELUCA HECTOR F·Filed 2012·Granted Nov 19, 2019·0 cites·53 claims
- 4050US9290447B2(20R) and (20S)-24-(p-toluenesulfonyloxy)-25,26,27-trinorvitamin D3 analogs and their usesDELUCA HECTOR F·Filed 2012·Granted Mar 22, 2016·0 cites·16 claims
- 4149US2013053356A12-methylene-19,23,24-trinor-1alpha-hydroxyvitamin d3DELUCA HECTOR F·Filed 2012·Application pending·0 cites
- 4249US2009281340A11alpha-hydroxy-2-(3'-hydroxypropylidene)-19-nor-vitamin d compounds and methods of making and treatment thereofDELUCA HECTOR F·Filed 2009·Application pending·0 cites
- 4348US8754067B222-haloacetoxy-homopregnacalciferol analogs and their usesDELUCA HECTOR F·Filed 2011·Granted Jun 17, 2014·0 cites·42 claims
- 4447US2005203071A1Use of carbon-2-modified-19-nor-vitamin d analogs to induce the formation of new boneDELUCA HECTOR F·Filed 2003·Application pending·0 cites
- 4545US8178517B26-methylvitamin D3 analogs and their usesDELUCA HECTOR F·Filed 2010·Granted May 15, 2012·0 cites·29 claims
- 4644US2008031957A1Pulmonary delivery of 1alpha,25-dihydroxyvitamin D3 and co-administration of parathyroid hormone or calcitoninDELUCA HECTOR F·Filed 2007·Application pending·0 cites
- 4744US2008249068A1Method of Extending the Dose Range of Vitamin D CompoundsDELUCA HECTOR F·Filed 2007·Application pending·0 cites
- 4842US2013178449A12-Methylene-20(21)-Dehydro-19,24,25,26,27-Pentanor-Vitamin D AnalogsDELUCA HECTOR F·Filed 2012·Application pending·0 cites
- 4941US8993547B23-desoxy-2-methylene-19-nor-vitamin D analogs and their usesDELUCA HECTOR F·Filed 2012·Granted Mar 31, 2015·0 cites·43 claims
- 5041US2012283228A12alpha-Methyl and 2beta-Methyl Analogs of 19,26-Dinor-1alpha,25-Dihydroxyvitamin D3 and Their UsesDELUCA HECTOR F·Filed 2012·Application pending·0 cites
Showing the top 50 of 59 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when DELUCA HECTOR F files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →